SECsense Logo

Gilead Sciences, Inc. 8-K Report: Key Updates for July 30, 2025

$GILD
Form 8-K
Filed on: 2025-08-04
Source
Gilead Sciences, Inc. 8-K Report: Key Updates for July 30, 2025

From the provided section of the financial report, the key information extracted is as follows:

  1. Entity Information:
  • Company Name: Gilead Sciences, Inc.
  • CIK (Central Index Key): 0000882095
  • Address: 333 Lakeside Drive, Foster City, CA 94404
  • Phone Number: 650-574-3000
  1. SEC Filing Details:
  • Filing Type: 8-K (a report used to announce major events that shareholders should know about)
  • Filing Date: July 30, 2025
  • SEC File Number: 0-19731
  • IRS Employer Identification Number (EIN): 94-3047598
  1. Stock Information:
  • Type of Stock: Common Stock
  • Par Value: $0.001 per share
  • Ticker Symbol: GILD
  • Exchange: NASDAQ
  1. Reporting Period:
  • Report Period Start Date: July 30, 2025
  • Report Period End Date: July 30, 2025
  1. XML Metadata:
  • The report is formatted in XBRL (eXtensible Business Reporting Language), which is commonly used for financial statements.

Insights:

  • The filing on July 30, 2025, indicates that Gilead Sciences is likely reporting a significant event or update relevant to its shareholders.
  • The fact that Gilead's common stock is listed on NASDAQ under the ticker GILD allows investors to assess its trading performance and market presence.
  • The use of XBRL suggests that the company is adhering to modern reporting standards, which can enhance transparency and comparability of financial data.

This summary provides a concise overview of the essential information from the financial report, as well as insights into the company's operations and disclosure practices.